关于CREB结合蛋白 (CREBBP):基于结构的临床抑制剂开发前景
Rongxing Liu1, Jiaxin Li1, Qing Nian2
1Department of Pharmacy, The Second Affiliated Hospital of Army Medical University, 83 Xinqiao Road, Shapingba, Chongqing, China.
Translational oncology
|August 19, 2025
概括
基酸转移酶 (HAT) 抑制剂,特别是CREBBP (也称为CBP),对于治疗血液形成性恶性瘤等癌症至关重要. 本综述强调了CBP结构,用于开发新的选择性CBP抑制剂.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 蛋白质乙化,由基因素乙转移酶 (HAT) 和基因素脱乙酶 (HDAC) 酶调节,在生物过程中至关重要.
- 虽然存在众多的胰岛素脱乙酶抑制剂,但选择性胰岛素乙转移酶抑制剂在临床试验中不太常见.
- CREBBP (也称为CBP) 是一种关键的HAT,因其在信号通路中的作用而涉及各种疾病,特别是造血性恶性瘤.
研究的目的:
- 审查CREBBP (CBP) 在开发向抑制剂中的结构重要性.
- 为设计用于治疗应用的新型选择性CBP抑制剂提供参考.
主要方法:
- 文献综述,重点关注CBP结构与活动关系.
- 对现有和潜在的CBP抑制剂开发策略的分析.
主要成果:
- 在各种瘤类型中,CBP经常过度表达和激活,这凸显了其作为治疗点的潜力.
- 了解CBP的结构对于设计强效和选择性抑制剂至关重要.
结论:
- 向CBP为癌症治疗提供了一个有前途的途径,特别是在造血性恶性瘤中.
- 对CBP结构的进一步研究将有助于开发有效的CBP向药物.
相关概念视频
Protein-protein Interfaces
13.2K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
13.2K
Ligand Binding Sites
13.2K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
13.2K
Covalently Linked Protein Regulators
7.1K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
7.1K
Eukaryotic Transcription Inhibitors
10.0K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
10.0K
Conserved Binding Sites
4.3K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
4.3K
Protein-Drug Binding: Mechanism and Kinetics
931
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
931


